Abstract
Introduction
Dyspepsia means a symptom or set of symptoms that is (are) considered to arise from the gastroduodenal region. 1 The dyspeptic symptoms are epigastric pain, epigastric burning, postprandial fullness or early satiety. Bloating, nausea and vomiting may co-exist and are supportive symptoms but not included in definitions. 1,2 Typical symtoms of gastroesophageal reflux disease such as heartburn and acid eructation have been excluded from the dyspeptic symptoms as these primarily arise from the oesophagus. 1 Dyspepsia is a worldwide health and economic problem. It is associated with significant morbidity and impairment of quality of life. 3 It imposes a huge burden on health care system due to its high prevalence and resource utilization from consultation, investigations, drug consumption and considerable time loss from the work. 3, 4, 5 Dyspepsia is caused by different diseases. There are various investigations to determine the underlying cause of dyspepsia. Treatment options are also variable. It is often a challenge to primary care physicians to find the best approach. But it is important to have a cost effective management strategy for the patients and health care services. There are differences in predominant causes of dyspepsia in different countries. Investigation facilities and available health resources are also different in different countries. For these reasons, different international and regional guidelines have recommended that management strategy of dyspepsia should be tailored for each country. [6] [7] [8] In Bangladesh; investigation facilities for evaluation of dyspepsia are limited. In fact, in many parts of the country there are no investigations facilities at all. Management of dyspepsia in such situation is really difficult for the general practitioners who deal with most of the patients. International and regional guidelines have not addressed the issue of management of dyspepsia in such resource constraint situation. In this article, we have reviewed the current literature on evaluation and treatment of dyspepsia and discussed the preferred strategy in primary care settings in Bangladesh.
Practice points
• Dyspepsia means a symptom or set of symptoms that is (are) considered to arise from the gastroduodenal region.
• There are many causes of dyspepsia which vary from country to country • Guidelines for management should be based on local facts.
Epidemiology
The prevalence of dyspepsia varies from 7% to 41% and it is estimated that 25% of the general population suffer from dyspeptic symptoms worldwide. [9] [10] [11] The prevalence of dyspepsia in general population is 8 % to 41% in Bangladesh. [12] [13] This difference in prevalence may be due to different populations studied or differences in definition of dyspepsia used. Epidemiological factors that influence the prevalence of dyspepsia are race, culture, age, sex, alcohol consumption, cigarette smoking, use of non-steroidal anti-inflammatory drugs (NSAIDs), H. pylori infection and obesity. 14 About 30% of the dyspeptic patients seek medical consultation -mostly from primary care physicians. More than 50% dyspeptic subjects take medications most of the days and 30% take leave from the work occasionally in the United Kingdom 
Practice points
• Functional dyspepsia is the commonest cause of dyspepsia.
• A small number of patients have peptic ulcer disease which is associated with H. pylori infection in the majority.
Investigations
The initial management of a patient with dyspepsia should begin with a thorough history and clinical examination. Clinical features do not reliably differentiate between organic and functional disease. 18, 19 Endoscopy of upper gastrointestinal tract is the most important investigation to establish the diagnosis of functional dyspepsia in which no organic lesion is found. However, it is not possible and cost-effective to perform endoscopy on every patient with dyspepsia. Moreover, it is an invasive procedure, costly and not widely available. The possibility of having organic disease is high in presence of certain symptoms and signs known as 'alarm features'. (Table-III Practice points • Vast majority of patients are treated after clinical evaluation without any investigation.
• Patients with `alarm feature` should be investigated.
Management of un-investigated dyspepsia in the community by general practitioner
Test-and-treat and empiric acid suppressive therapy are two common strategies for the diagnosis and treatment of uninvestigated dyspepsia. Test-and treat strategy implies that presence of helicobacter pylori infection should be tested non-invasively and if found positive, should be treated by eradication therapy. It results in cure of helicobacter pylori infection and cure of peptic ulcer disease if it is present. In a number of functional dyspepsia patients, Helicobacter pylori eradication is followed by symptomatic improvement. Endoscopy is thus avoided in a good proportion of patients. Many Western guidelines have recommended that if prevalence of Helicobacter pylori infection is high (>10%-30%), patients should undergo test and treat strategy. [6] [7] [8] 22, 23 Empiric acid suppressive therapy means treating patients with proton pump inhibitors (PPIs) empirically. It does not cure Helicobacter pylori infection particularly in those with underlying ulcer disease, resulting in frequent relapse of ulcer symptoms. The Asia-Pacific Working Party recommends antisecretory therapy (Proton pump inhibitors or H2 receptor blocker) or prokinetics at standard dose with duration of 2-4 weeks and considers this approach to be a less expensive alternative and appropriate strategy in countries with limited health resources. 24 This recommendation is based on the fact that significant percentage of patients will improve with this treatment and subsequently have a long-term remission. A recent review of literature found no significant differences between test-and-treat and empiric acid suppressive therapy strategies in terms of symptom control and cost-effectiveness. 25 A current guideline recommends that either strategy can be used. 26
Bangladesh perspective
The prevalence of helicobacter pylori infection is high in Bangladesh. More than 90% apparently healthy adults have been found to have antibody to Helicobacter pylori in the blood. 27 Another study has demonstrated that 84% children become Helicobacter pylori infected by 6-9 years of age in Bangladesh. 28 In a community survey, the prevalence of peptic ulcer disease was also found to be high (15%). 13 Test and treat approach can be useful in areas where helicobacter pylori infection can be diagnosed by non-invasive tests such as urea breath test (UBT), stool antigen test (SAT) and serological test. Adoption of test and treat strategy widely in Bangladesh has a number of limitations. Firstly, facilities for non-invasive helicobacter pylori test are not available in majority areas of Bangladesh. Urea breath test and Stool antigen test are preferred methods of diagnosing helicobacter pylori by non-invasive method. But these tests are commercially available in very limited centers. So, the only test available in Bangladesh to detect helicobacter pylori non-invasively is serological test which doesn't necessarily indicate active infection and is not useful as a test of eradication. This is because the test may remain positive for many years after successful helicobacter pylori eradication. Only validated IgG serology should be used due to variability in accuracy of different commercial tests and the favored method is ELISA. 23 The accurate serology test based on ELISA is not widely available in Bangladesh. Secondly, most studies have shown that helicobacter pylori eradication regimens in Bangladesh are not effective at internationally accepted rate of eradication (80%). [29] [30] [31] [32] [33] [34] Thirdly, a long-term follow up study from Bangladesh has shown that there is high recurrence of helicobacter pylori infection which is 39% at 5 years. 35 Considering the limited availability or unavailability of investigation facilities, poor eradication rate and high recurrence rate of helicobacter pylori therapy, the preferred method should be empirical therapy with proton pump inhibitors or H2 receptor blocker in primary care setting in Bangladesh (Figure-1) .
stated that H. pylori testing and eradication should be part of the management strategy for all patients in Asia who present with dyspepsia where socio-economic conditions allow. Considering the widespread lacking of investigation facilities, higher cost, low eradication rate, high recurrence rate and symptoms improvement in a small number of patients, H. pylori eradication should not be routine part of management strategy for functional dyspepsia in Bangladesh.
Antidepressants and anxiolytics such as amitriptyline, imipramine,fluoxetine etc. have a role in the management of functional dyspepsia. These drugs are useful in refractory to treat patients and their action is mediated through central mechanism. Psychological disturbances and sleep disturbances may be important determinants of response to anti-depressant treatment in functional dyspepsia patients. Specific food ingredients such as chilli, spice and fats may provoke dyspeptic symptoms and dietary modification can be considered in patients with functional dyspepsia.
Practice points
• PPI in standard dose is effective in a number of patients. Higher dose confer no additional benefit. • Prokinetics may be effective in a small number of patients.
• Very few patients get benefit from H. pylori eradication therapy.
• Antidepressants and anxiolytics may help some patients.
• No specific dietary recommendation is given.
Management of patients with peptic ulcer disease
There are various acid neutralizing drugs, mucosa protective agents and anti-secretory drugs for the treatment of peptic ulcer disease. All the patients with peptic ulcer disease should be tested for H pylori and if positive should be offered anti H pylori therapy. Treatment with PPIs for four weeks in duodenal ulcer and 6-8 weeks in gastric ulcer lead to ulcer healing rate of more than 90%. 36 The main benefit of H.pylori eradication therapy is low recurrence of ulcers. The one year recurrence of ulcer with antisecretory therapy is 50% to 80% 37 whereas H. Pylori eradication therapy associated with < 2% recurrence rate. 35 In uncomplicated duodenal ulcer, prolonging acid inhibition with PPI is not necessary after H. Pylori therapy. In complicated duodenal ulcers and gastric ulcers prolonging PPI is recommended. 23 H pylori eradication and endoscopic healing should be confirmed in gastric ulcers after 4 weeks of treatment. 23 No dietary restriction is needed in patients with peptic ulcer disease. Patients should avoid those foods that precipitate symptoms. 36 Common treatment regimens for H. pylori eradication available in Bangladesh are shown in Table- IV.
The available options for patients who do not respond to initial empiric PPI therapy for 2-4 weeks are: step up therapy (changing dose or drug class) test-and-treat for H pylori or endoscopy. Same treatment is justified in patients who responded to initial PPI therapy and in whom symptoms recur. [6] [7] [8] Practice points • Test and treat therapy-non-invasive test for H. pylori and eradication therapy for patients who test positive.A proportion of patients improve. But non invasive tests are not available in most parts of Bangladesh.
• Empirical acid suppressive therapy-results are similar to the test and treat method.
• Prevalence of H. pylori infection is high in Bangladesh.
Eradication therapy has a lower success rate compared to western countries. Recurrence rate is high.
Management of functional dyspepsia
As functional dyspepsia is a heterogeneous disorder the treatment is also variable. 
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Bangladesh Med J. 2013 May; 42 (2) Extending the duration of PPI-clarithromycin containing triple regimen treatment from 7 days to 10-14 days improves the eradication success by approximately 5%-7% and may be considered. 23 After failure of PPIclarithromycin containing therapy levofloxacin based therapy is an option in Bangladesh.
Practice points
• All patients with peptic ulcer disease should be treated for presence of H. pylori infection and eradication therapy should be given to those who are positive.
Management of NSAIDS associated dyspepsia
NSAIDs are one of the most commonly used drugs all over the world. 
Practice points
• If possible NSAIDs therapy should be stopped.
• If continuous NSAIDs therapy is necessary, concomitant PPI therapy may lower the incidence of peptic ulcer and its complications.
Dyspepsia is a common problem. Primary care physicians deal with most of the patients with dyspepsia. After investigations majority of the patients are found to have functional dyspepsia. Two most common strategies for the management of uninvestigated dyspepsia are: test-and-treat and empiric acid suppressive therapy. Recent evidence suggests no significant differences between test-and-treat and empiric acid suppressive therapy strategies in terms of symptom control and cost-effectiveness. In most areas of Bangladesh the diagnostic facilities are lacking. Anti H. pylori therapy is associated with low eradication rate and high recurrences in this country. If we consider these factors, the preferred strategy for uninvestigated dyspepsia without alarm features and age less than 50 years should be empiric acid suppressive therapy in primary care practice in Bangladesh. In patients who do not respond to initial empiric therapy, investigations including upper GI endoscopy should be undertaken. Investigations are also warranted in all patients who present with `alarm feature' and who are more than 50 years of age. 
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